Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.
![Blast off!](https://d1sg0ksu7mr16v.cloudfront.net/admin_uploads/emails/April/EFF_rocket.gif)
Browse Other Projects on Experiment
Related Projects
Exploring an age-old question: Can we demystify skin color?
In 2005, our lab uncovered one of the most pervasive genetic mutations on SLC24A5, the contributor to the...
Can we use our immune cells to fight lung disease?
Acute respiratory distress syndrome (ARDS) is a common deadly illness often seen in the intensive care unit...
Can viral molecular structures cause cancer?
Epstein-Barr virus (EBV) infects 9 out of 10 people and can lead to cancers such as Hodgkin's, Burkitt's...